Annual Report 2014

Imperial Innovations has published its Annual Report and Accounts for the year ended 31 July 2014. Click the button below to visit the Annual Report website.

View Website

Imperial Innovations

We are focused on commercialising the best in UK academic research, drawn from academic centres within the 'golden triangle' formed by Cambridge, Oxford and London. We have end-to-end capability, taking research at the earliest stage and working with it right through to commercialisation.

Read more

CEO Interview

Recent interviews and presentations by CEO Russ Cummings

Watch the interviews

Imperial Innovations

We are a technology commercialisation company, combining the activities of technology transfer, intellectual property licensing and protection, company incubation and investment. We are focused on the commercialisation of the most promising opportunities from a broad range of technology sectors, with particular expertise in therapeutics, medtech, engineering & materials and ICT.

About us Our people Investor relations

£198.3m

invested in UK innovation

During the six months ended 31 January 2015 we invested £22.4 million in our portfolio.

£346.0m

Raised by Innovations

to support investment in and development of our portfolio of technology businesses.

£1 billion

invested in UK innovation

Alongside co-investors, £1 billion has been committed to our portfolio companies since 2006

£1.4 billion

Research Funding

received each year by the universities we focus on (Imperial, Oxford, Cambridge, UCL)

£22.4m

Invested

During the six months ended 31 January 2015 we invested £22.4 million in our portfolio.

35

Accelerated Growth Companies

The focus of our time and capital

Technology Transfer

Technology Transfer

Our Technology Transfer team works with Imperial College London academics and students.

We manage the translation of an idea into practice, working with academic inventors throughout the process of commercialisation, leading ultimately to licensing to industry partners, or the creation of new ventures.

Find out more
Ventures

Ventures

Our ventures team creates, nurtures and invests in new technology ventures based on IP

We work to develop new company opportunities based on leading UK academic research, working with Imperial College London (& our own Technology Transfer team), The Universities of Oxford & Cambridge and UCL.

Find out more

Imperial Innovations news

More news
News
Innovations obtains further £50m loan facility from EIB to strengthen UK biotech & life science investment

£50 million loan facility will strengthen investment rate and scale in medtech ...

Read article
News
Encouraging trial results for cystic fibrosis gene therapy treatment

Imperial Innovations is pleased to note the announcement this morning that a ...

Read article
09 Oct
05 Oct
02 Oct

Portfolio overview

View portfolio

We have identified four particular areas of expertise, shown in the diagram below. As at 31 January 2015, the value of the top 20 investments in our portfolio stood at £241.3 million.

Portfolio subsectors
  • Therapeutics
  • Medtech
  • Engineering/Materials
  • ICT/Digital
More about our leading investments
Diagram
Circassia
Sector Investment amount Investment stage
Therapeutics £25.5m Listed
Overview

A clinical-stage specialty biopharmaceutical company developing a range of novel immunotherapies

View profile
Orthonika
Sector Investment amount Investment stage
Medtech Seed
Overview

Complete replacement for knee meniscus

View profile
Concirrus
Sector Investment amount Investment stage
ICT/Digital £3.0m Series A
Overview

Internet of Things solutions provider specialising in fully integrated business solutions around connected product intelligence.

View profile

Investment details

View
Share price: 482.50p
Diagram
Key information

Sector: Financial Services
Activities: Technology commercialisation, incubation and investment
EPIC: IVO
Status: AIM
Year end: 31 July